How kidney transplant patients feel about using artificial intelligence in medicine
Official title: Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine
Run by Paris Translational Research Center for Organ Transplantation · NCT07600541 · Data updated 2026-11-12
This international survey asks adults who have had a kidney transplant how they feel about AI tools that predict graft loss and what it might mean for their daily care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Paris Translational Research Center for Organ Transplantation Academic / other |
| Locations | 2 sites (Paris, Île-de-France Region and 1 other locations) |
| Status | Recruiting |
| Started | April 15, 2026 |
| Main results expected | September 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | May 20, 2026 |
| Trial ID | NCT07600541 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who have received a kidney transplant and can read French or English, with access to the online questionnaire and able to provide electronic consent.
✕Probably not a fit
Individuals unwilling or unable to engage with online questionnaires or provide electronic consent may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, multicenter survey explores kidney transplant recipients' views on artificial intelligence in medicine, focusing on a system that estimates the risk of graft loss. Participants complete an online questionnaire in French or English, with responses analyzed using large language models and human review to ensure accuracy. The goal is to understand expectations, concerns, and the potential impact of AI-driven predictions on patient care, ethics, and transparency in transplantation. The study builds on existing predictive tools like iBox and seeks patient-centered insights to guide responsible deployment of AI in this field. Recruitment includes adult participants at selected centers in France and the United States.
Why it matters
Potential benefit: If successful, the study could inform how AI tools are communicated and integrated in transplant care to better align with patient values and concerns.
How similar studies have gone: Prior work on AI in transplantation has focused on clinical performance; patient-perception studies are less common but are increasingly recognized as important for ethical deployment.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Inclusion criteria * Age ≥ 18 years * Fluency in French or English * Electronic consent given * Exclusion criteria * Severe cognitive impairment preventing comprehension * Technical inability to access the questionnaire
Where it's running
-
Le flambeau de la vie
Paris, Île-de-France Region, France Recruiting -
Nice Pasteur
Paris, Île-de-France Region, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Omnisol-preserved kidneys before transplant (hypothermic machine perfusion)
This study tests whether using Omnisol during hypothermic machine perfusion before kidney transplant can improve early graft function compared with standard preservation.
-
How Propofol and Sevoflurane Affect miRNA in Living Kidney Donors
This study tests whether using propofol or sevoflurane during donor nephrectomy changes levels of miRNAs in living kidney donors.
-
Effects of general vs spinal-epidural anesthesia on kidney transplant biomarkers
This study tests whether sevoflurane general anesthesia or combined spinal-epidural anesthesia changes markers of cellular stress and protective peptides in adults undergoing kidney transplantation.
-
Personalized therapeutic stories for children after kidney transplant.
We will test whether clinician-supervised AI can create age-appropriate, personalized therapeutic stories for children aged 5–12 who have received a kidney transplant and their families.
-
Treating blood vessel problems after a kidney transplant
This effort will try catheter-based angioplasty and advanced imaging to see if they help kidney transplant recipients with graft dysfunction or stubborn high blood pressure from possible transplant blood‑vessel problems.
-
AIC263029 in kidney transplant recipients with BK virus infection
This trial tests whether AIC263029 is safe and tolerable and can lower BK virus levels in adults who recently had a kidney transplant and have BK viremia, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.